Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
I wonder if today's 750k sell was him getting out. Whoever it was it has led to a bit of a topple in the SP.
The £6 mark should be reached some time next week and I expected the Brokers Target Price will be hit some time during 2017.
Kenny Me too. Staying well clear. There only appears to be One Direction for this one.
Indeed, I've dipped in and out of here and made some decent profits in the past, but perhaps sold a bit early last time rather than wait for it to reach £8+ back in mid 2014. However this time I do intend to wait for it to get there.
Iswhatitis Interesting Post. Are you suggesting that as Redstone Connect have found solutions for UBM (eg. extending OneSpace to their U.S. HQ) that in the future they may also acquire our little company for what to them would be loose change?
All today's volume buying has not occurred by chance. It can be assumed that some news has leaked. Perhaps we will now get an RNS so that we are all in the know. At least the SP has finally had a tick up:)
Sold - 0 Bought - 17,892,593 A tick up might now be expected???
Today has seen buy after buy after buy, including 3 biggies £1m, £2.5m & £3m and all but one of the buys have been at the full Ask, yet still no movement in the SP. Very odd.
In view of the fact that the SP went up after all those grey trades at 1.2p we may assume that they were buys. However just why one sell of 250k shares sent the price back down again is a mystery.
The initial mark up at opening and then the steady strength yesterday led me to believe that this had definitely bottomed on Thursday at £5.51 so I finally ditched some banking shares that were both up over 40% in just over 3 months to join the Party here. I'd be more than happy to see a similar return in say the next 6 months.
Just waiting for this to bottom before having a punt. The question is, where is the bottom. Brokers still have a target price of £8+ so even if I don't judge the bottom correctly, in the longer term it should still be a decent investment.
Probably not as the spread has widened downwards. However yesterday it was very hard to determine what were buys and sells, particularly after a string of apparent sells including a 1m and 2 x 500k sent the price upwards. It is appalling how the published prices of trades is so misleadingl.
You could hear a pin drop in here, but would rather hear an RNS drop!!
On Thursday 24th any trades below 1.37 were sells and any trades at 1.40 and above were buys. Hence the end of day trade of 2m was a buy. Someone is building a decent sized stake by the looks of it. It is very odd that the SP has remained static whilst these sizeable purchases of 3 x 2m have taken place this week.
And for the second day in a row!!! Time to pay a bit more attention.
An acquisition and NO PLACING :) Quite the opposite of what the trolls had predicted.
CEO Summary Louise Makin, BTG's CEO, commented: "The business has performed well during the first half, and the outlook for the full year is strong. We have the capabilities and financial strength to take advantage of the increasing opportunities we are seeing to expand our Interventional Medicine business. By accelerating our growth strategy through reinvestment of our cash flows to maximise the value of and expand the current portfolio, we can build leadership positions in selected areas of interventional medicine and thereby create sustainable value for shareholders." Outlook BTG has performed well in the first half, with double-digit revenue growth, strong free cash flow and disciplined cost control. Through the acquisition of Galil Medical we have strengthened our portfolio, capabilities and leadership in Interventional Medicine, which is our fastest growing and highest revenue business. We have the resources and capabilities to capitalise on the expanding opportunities we see in Interventional Medicine, by reinvesting our strong cash flows into further commercial expansion, pipeline development and acquisitions. In this way we will deliver double-digit compound annual revenue growth, cement our leadership in our chosen Interventional Medicine markets and create significant value for shareholders. In view of the above, it was perhaps surprising to see the SP down over 5% today.
See the below link from 11th October, which I don't think has been shared before. http://www.fiscalstandard.com/2016/10/11/redstoneconnect-plc-ord-shs-0-1p-lonreds-receives-buy-rating-from-cantor-fitzgerald-analysts/ After a previous suggested target price of 13p when Charles Stanley were the Brokers in 2014 we will no doubt be cautious about C.F's target price. However it is now a very different company, with a very different CEO and C.F. are no Charles Stanley.
Greybadger Just noticed that the post which prompted my one along with someone elses reply to it have been deleted, hence my post now looks out of place.
Greybadger I've always thought that your posts have been fair and well balanced and can assure you that you were not in my thoughts early last Friday morning. There are a couple of other posters who for about 2 years regularly deramp whenever the SP falls. By the way, a good summary in you last post.